Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

BioAtla (BCAB) Non Operating Income (2020 - 2025)

BioAtla (BCAB) has disclosed Non Operating Income for 6 consecutive years, with -$1.0 million as the latest value for Q4 2025.

  • For Q4 2025, Non Operating Income fell 176.54% year-over-year to -$1.0 million; the TTM value through Dec 2025 reached -$814000.0, down 119.53%, while the annual FY2025 figure was -$1.0 million, 124.81% down from the prior year.
  • Non Operating Income hit -$1.0 million in Q4 2025 for BioAtla, up from -$2.0 million in the prior quarter.
  • Across five years, Non Operating Income topped out at $2.3 million in Q1 2025 and bottomed at -$2.0 million in Q3 2025.
  • Average Non Operating Income over 5 years is $262100.0, with a median of $85500.0 recorded in 2021.
  • Year-over-year, Non Operating Income soared 12330.0% in 2024 and then plummeted 390.79% in 2025.
  • BioAtla's Non Operating Income stood at -$939000.0 in 2021, then soared by 96.81% to -$30000.0 in 2022, then increased by 10.0% to -$27000.0 in 2023, then skyrocketed by 5137.04% to $1.4 million in 2024, then crashed by 176.54% to -$1.0 million in 2025.
  • According to Business Quant data, Non Operating Income over the past three periods came in at -$1.0 million, -$2.0 million, and -$64000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.